Based on the results of this study, the benign imaging of 68Ga-FAP-2286 in advanced lung cancer, especially the imaging of metastatic lymph nodes and bone lesions, provides a basis for the treatment of 177Lu-FAP-2286 in metastatic lung cancer. This evidence concerns the gene FAP and lung cancer.